Immunocore Holdings plc (IMCR)
NASDAQ·Healthcare·Biotechnology
$28.72
+1.95%
Mkt Cap $1.69B
Analyst Ratings
No recent rating data.
Price Target (14 analysts)
$47.25
Range $36.00 – $60.00
Implied Upside
+64.5%
Consensus $47.25 vs current $28.72
NASDAQ·Healthcare·Biotechnology
$28.72
+1.95%
Mkt Cap $1.69B
No recent rating data.
Price Target (14 analysts)
$47.25
Range $36.00 – $60.00
+64.5%
Consensus $47.25 vs current $28.72